Inventor
ROBERT A. VOLKMANN
Inventor
US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes26%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium6%
C07KPeptides4%
C07HSugars2%
C12NMicroorganisms or enzymes2%
C12YEnzymes2%
PatentTitleYear
12,509,451Heteroaryl amide inhibitors of CD38202512,427,157Methods for treatment of diseases involving acidic or hypoxic diseased tissues202512,410,262Peptide conjugates of cytotoxins as therapeutics202512,358,929NMDA receptor modulators and uses thereof202512,234,212Peptide conjugates of microtubule-targeting agents as therapeutics202512,162,890Heteroaromatic NMDA receptor modulators and uses thereof202412,161,624Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B202412,145,909N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[C]pyrrole negative allosteric modulators of NR2B202411,866,444Oxabicycloheptane prodrugs202411,648,253Thienopyrimidinone NMDA receptor modulators and uses thereof202311,634,508Peptide conjugates of cytotoxins as therapeutics202311,555,019Peptide conjugates of microtubule-targeting agents as therapeutics202311,541,057Thienopyrimidinone NMDA receptor modulators and uses thereof202311,542,264Heteroaromatic NMDA receptor modulators and uses thereof202311,274,107NMDA receptor modulators and uses thereof202211,236,104Heteroaromatic NMDA receptor modulators and uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to CADENT THERAPEUTICS INC (4)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to NOVARTIS AG (5)· patent assignee history
2023–2025Patents assigned to CYBREXA 2 INC (2)· patent assignee history
2023–2025Patents assigned to CYBREXA 3 INC (2)· patent assignee history
2025Patents assigned to BUCK INST RES AGING (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NOVARTIS AG | 5 | 2023–2025 |
| CADENT THERAPEUTICS INC | 4 | 2022–2023 |
| CYBREXA 2 INC | 2 | 2023–2025 |
| CYBREXA 3 INC | 2 | 2023–2025 |
| BUCK INST RES AGING | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 16 | 2022–2025 |